Prevalence of Transfusion-Transmitted Infections in Beta-Thalassemia Major Patients: A Cross-Sectional Study

Document Type : Original Article

Authors

1 Department of Pediatrics, Ali Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran

2 Department of Pediatrics, Children and Adolescents Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

3 Zahedan University of Medical Sciences, Zahedan, Iran

Abstract
Introduction: Beta-thalassemia major is an inherited hemoglobin disorder caused by defective synthesis of the beta-globin chain. Patients with beta-thalassemia major require regular blood transfusions, exposing them to transfusion-transmitted infections (TTIs). This study aimed to evaluate the prevalence of TTIs among beta-thalassemia major patients.
Methods: In this descriptive cross-sectional study, all 748 patients with transfusion-dependent beta-thalassemia major who were referred to Ali-Asghar Children’s Hospital in Zahedan, Iran, during 2017–2018 were included. A census sampling method was used, and all eligible patients during the study period were evaluated. The presence of antibodies against hepatitis B, hepatitis C, and HIV was assessed using the enzyme-linked immunosorbent assay (ELISA), and PCR was performed to confirm hepatitis C and HIV infections. Demographic characteristics, including age and gender, and laboratory findings were extracted from patients’ medical records. Data were analyzed using SPSS version 25. Descriptive statistics, including frequency, percentage, mean, and standard deviation, were used to summarize the data.
Results: The mean age of the patients was 15.57 ± 8.6 years. Among them, 392 (52.5%) were male, and 356 (47.5%) were female. The most common transfusion-transmitted infection was hepatitis C, observed in 8.02% (60 patients). Hepatitis B was found in 0.8% (6 patients), and HIV in 0.1% (1 patient). The mean age of patients with hepatitis C was 15.53 ± 6.4 years, while those with hepatitis B had a mean age of 15.3 ± 5.03 years. The highest prevalence of TTIs occurred in patients with longer transfusion histories. Additionally, the most common genotype of the hepatitis C virus was 1a (56.6%).
Conclusion: The findings of this study revealed that hepatitis C is the most common transfusion-transmitted infection among beta-thalassemia major patients, with genotype 1a being the predominant strain. Furthermore, an increased frequency of transfusions was associated with a higher risk of TTIs. Thus, greater attention to donor screening tests and appropriate immunization strategies is essential to reduce the prevalence of infections in patients requiring frequent transfusions.

Keywords

Subjects

1.        Miri-Aliabad G, Fadaee M, Khajeh A, Naderi M. Marital status and fertility in adult Iranian patients with β-thalassemia major. Indian J Hematol Blood Transfus 2016;32(1):110-3. doi:10.1007/s12288-015-0510-9
2.        McGann PT, Nero AC, Ware RE. Clinical features of β-thalassemia and sickle cell disease. Adv Exp Med Biol 2017;1013:1-26. doi:10.1007/978-1-4939-7299-9_1
3.        Miri-Aliabad G, Rezaeifar A, Salarzaei M. Comparison of immunoglobulins status in splenectomized and non-splenectomized patients with major β-thalassemia. J Pediatr Rev 2022;10(2):161-6. doi:10.32598/jpr.10.2.951.2
4.        Yousefian S, Miri-Aliabad G, Saleh R, Khedmati M. Association of body mass index and serum ferritin level in pediatrics with β-thalassemia major disease. Iran J Pediatr Hematol Oncol 2022;12(1):34-40. doi:10.18502/ijpho.v12i1.8359
5.        Miri-Aliabad G, Asgarzadeh L, Dorgalaleh A, Bahraini M. Prevalence of acute complications of transfusion in children with β-thalassemia major in southeast Iran: a prospective study. J Kerman Uni Med Sci 2023;30(4):229-32. doi:10.34172/ jkmu.2023.38
6.        Miri-Aliabad G, Tabatabaei SM, Vaezi Z, Amini A, Asgarzadeh L. Causes of birth of more than one thalassemia major patient in families in south-east of Iran: lessons for prevention programs. Health Scope 2021;10(3): e116634. doi:10.5812/ jhealthscope.116634
7.        Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010;5:11. doi:10.1186/1750-1172-5-11
8.        Amirabadi F, Saravani S, Miri-Aliabad G, Khorashadi-Zadeh M. The association between dental health status and oral health-related quality of life of children diagnosed with β-thalassemia major in Zahedan city, Iran. Int J Pediatr 2019;7(2):8985-91. doi:10.22038/ijp.2018.34517.3034
9.        Ansari S, Azarkeivan A, Miri-Aliabad G, Yousefian S, Rostami T. Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia major. Caspian J Intern Med 2017;8(3):159-64. doi:10.22088/cjim.8.3.159
10.      Miri-Aliabad G, Naderi M, Izadi-Nia H. Burkitt leukemia in a child with β-thalassemia major. J Kerman Uni Med Sci 2022;29(1):91-4. doi:10.22062/jkmu.2022.91868
11.      Borgna-Pignatti C, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev Hematol 2011;4(3):353- 66. doi:10.1586/ehm.11.29
12.      Riaz M, Abbas M, Rasool G, Baig IS, Mahmood Z, Munir N, et al. Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: a systemic review. Int J Immunopathol Pharmacol 2022;36:3946320221096909. doi:10.1177/03946320221096909
13.      Yasmeen H, Hasnain S. Epidemiology and risk factors of transfusion transmitted infections in thalassemia major: a multicenter study in Pakistan. Hematol Transfus Cell Ther 2019;41(4):316-23. doi:10.1016/j.htct.2019.03.008
14.      Chattopadhyay S, Mukherjee R, Nandi A, Chakraborty PS, Rit K, Chaudhuri SJ. Prevalence of hepatitis B&C in thalassemia patients in a tertiary care hospital in West Bengal. IOSR J Dent Med Sci 2014;13(7):68-70.
15.              Waheed U, Saba N, Wazeer A, Ahmed S. A systematic review and meta-analysis on the epidemiology of hepatitis B and hepatitis C virus among β-thalassemia major patients in Pakistan. J Lab Physicians 2021;13(3):270-6.
doi:10.1055/s-0041-1731110
16. Ehsan H, Wahab A, Anwer F, Iftikhar R, Yousaf MN. Prevalence of transfusion transmissible infections in β-thalassemia major patients in Pakistan: a systematic review. Cureus 2020;12(8): e10070. doi:10.7759/cureus.10070
17. Akhtar S, Abdul Nasir J, Hinde A. The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis. BMC Public Health 2020;20(1):587. doi:10.1186/s12889-020-8414-5
18. Bhuyan GS, Noor AU, Sultana R, Noor FA, Sultana N, Sarker SK, et al. Frequency of hepatitis B, C and HIV infections among transfusion-dependent β-thalassemia patients in Dhaka. Infect Dis Rep 2021;13(1):89-95. doi:10.3390/idr13010011
19. Miri-Aliabad G. Beta-thalassemia: an overview of epidemiology, clinical features, diagnosis, and management. Avicenna J Clin Med 2025;31(4):255-63. doi:10.32592/ajcm.31.4.255